Drug Insights

Making the Most Out of Synapse: Searching for Carvedilol

11 February 2024
2 min read

Carvedilol, sold under the trade name Coreg, is a medication that was first approved in Belgium in 1990. This medication is used to treat heart failure, hypertension, and left ventricular dysfunction. Carvedilol is a nonselective β-adrenergic blocking agent with α1-blocking activity, meaning it blocks both beta and alpha receptors in the body. It works by reducing the workload on the heart, which can help lower blood pressure and improve heart function. The chemical structure of Carvedilol is (±)-1­ (Carbazol-4-yloxy)-3-[[2-(o-methoxyphenoxy)ethyl]amino]-2-propanol. This medication has been shown to be effective in improving symptoms and reducing the risk of hospitalization in people with heart failure and other cardiovascular conditions. Click on the image below to begin the exploration journey of Carvedilol through the Synapse database!

图形用户界面, 应用程序, 电子邮件

描述已自动生成

You can search for the latest pharmaceutical information such as drugs, targets, patents, transactions, clinical results, etc. through the Synapse database. Come and experience it!

图形用户界面, 文本, 应用程序, 聊天或短信

描述已自动生成

Inmagene Activates Its Right to Secure Sole Global Licensing for IMG-007 and IMG-004 from HUTCHMED
Latest Hotspot
3 min read
Inmagene Activates Its Right to Secure Sole Global Licensing for IMG-007 and IMG-004 from HUTCHMED
11 February 2024
Inmagene Biopharmaceuticals has announced its intention to acquire a solo, global license with royalties for IMG-007, a non-eliminating humanized antibody targeting OX40, and IMG-004, a systemically administered BTK inhibitor with non-covalent, reversible mechanisms.
Read →
Synapse Simplified: How to Find Lamotrigine Information
Drug Insights
2 min read
Synapse Simplified: How to Find Lamotrigine Information
11 February 2024
Lamotrigine, approved by the US FDA on Dec 27, 1994, is a leading anticonvulsant drug developed by GlaxoSmithKline.
Read →
EMA Approves Review of Tisotumab Vedotin for Advanced Cervical Cancer Therapy
Latest Hotspot
3 min read
EMA Approves Review of Tisotumab Vedotin for Advanced Cervical Cancer Therapy
11 February 2024
European Medicines Agency Approves Review of Tisotumab Vedotin Filing for Relapsed or Spreading Cervical Cancer Therapy.
Read →
A Complete Guide to Searching Magnesium citrate on Synapse
Drug Insights
2 min read
A Complete Guide to Searching Magnesium citrate on Synapse
11 February 2024
Magnesium citrate is a type of small molecule drug that is a combination of magnesium and citric acid in a 1:1 ratio.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.